IOF PRESS RELEASE 6
MAY 11, 2002
Lisboa Congress Center, Portugal
Two UK researchers share €45,000 fellowship
International congress recognizes projects linking corticosteroids and osteoporosis, and effects of premature birth on skeleton development
Researchers from the United Kingdom shared the 2002 IOF-Claus Christansen Research Fellowship, worth €45,000. The grant, presented at the IOF World Congress on Osteoporosis, was presented to Dr. Eugene V. McCloskey, University of Sheffield Medical School and to Dr. Christine M. Smith, Northern General Hospital in Sheffield.
Dr. McCloskey's project, "Cost-effectiveness of different strategies for the management of steroid induced osteoporosis", focuses on the connection between corticosteroid use and osteoporosis. The project will address the relationship between bone mineral density and fracture in patients receiving corticosteroids, the efficacy of interventions in patients receiving corticosteroids and the cost-effectiveness of different strategies for assessment and treatment of individuals. Dr. McCloskey is honorary consultant with the WHO Collaborating Center for Metabolic Bone Disease, Sheffield, U.K.
Dr. Smith's project, "An investigation of the long-term effects of prematurity on the skeleton of young adults" compares 120 young adults who were born pre-term with a matched control group of young adults who were born at term. The study will examine if the deficit in bone mass at birth is carried through into adult life. Dr. Smith is a research associate with the Bone Metabolism Group, Section of Medicine, Division of Clinical Sciences at the University of Sheffield.
IOF offers the Claus Christiansen Research Fellowship every two years. The fellowship is valued at a maximum amount of €45,000 and eligibility is restricted to members of IOF's Committee of Scientific Advisors and national societies.
The fellowship, is named in honor of Professor Claus Christiansen, a renowned researcher who has made significant contributions to advancing the field of osteoporosis and to IOF.
The International Osteoporosis Foundation (IOF) is a worldwide organization dedicated to the fight against osteoporosis around the world. It brings together scientists, physicians, patient societies and corporate partners. Working hand in hand with its 139 member societies in 71 countries and other healthcare-related organizations around the world, IOF encourages awareness and prevention, early detection and improved treatment of osteoporosis.
The IOF World Congress on Osteoporosis is being held May 10-14, 2002 in Lisbon, Portugal. Some 5,000 participants are expected for the congress, expected to be the largest gathering ever of osteoporosis specialists from around the world. Abstracts from the congress are published in a supplementary volume of the journal Osteoporosis International. For more information visit the congress website: www.osteofound.org/wco/2002
IOF World Congress on Osteoporosis abstracts can be accessed on:
For more information contact Siofra Sharpe:
Click here to download this press release as a Word file